Abstract
Background
Functional defecatory disorders (FDDs) are highly prevalent around the world. Biofeedback is an effective treatment for FDDs. Traditionally, this treatment is performed by clinicians in a limited number of hospitals because of procedure-related expenses and a need for a dedicated procedure room. To make the biofeedback therapy more widely available, we have designed a novel wireless, smartphone-based biofeedback device, with the ultimate goal of performing the therapy at home. The aim of this pilot study was to investigate whether the developed device can be employed to treat patients with FDDs in a clinical setting, prior to employing it in a home setting.
Methods
From March 2018 to July 2018, we performed the biofeedback therapy using the newly developed wireless, smartphone-based device in patients with FDDs 30 min daily during weekdays for 2 weeks. A Visual Analogue Scale (VAS) for bowel satisfaction, Patient Assessment of Constipation‐Symptoms (PAC‐SYM), Patient Assessment of Constipation Quality of Life (PAC-QOL), and a balloon expulsion test were assessed at baseline and after the therapy.
Results
Thirteen patients were recruited and ten of them (mean age 70.3 ± 8.9 years, female:male ratio: 3:7) completed the study. Spontaneous bowel movements, complete spontaneous bowel movements, and VAS were all significantly increased after the therapy compared with baseline, respectively (6.5 ± 4.3 vs. 1.5 ± 2.2, p = 0.006; 3.1 ± 2.2 vs. 0.2 ± 0.6, p = 0.002; 49.5 ± 31.0 vs. 12.0 ± 9.2, p = 0.003). There was a significant decrease in the PAC-SYM and PAC-QoL after the biofeedback therapy (0.7 ± 0.6 vs. 1.4 ± 0.3, p = 0.001; 0.7 ± 0. 6 vs. 1.5 ± 0.4, p = 0.001). The therapy reduced the balloon expulsion time significantly (83.9 ± 68.8 s vs. 160.0 ± 36.7 s, p = 0.002). No obvious adverse events related to the procedure itself occurred.
Conclusions
Biofeedback training using the newly developed wireless, smartphone-based device is feasible in the clinic setting, and it seems to be a promising method for improving constipation and related symptoms in patients with FDDs. These findings could be used to develop a much-needed, home-based, suitably powered, randomized, controlled clinical trial.
References
Bocchini R, Chiarioni G, Corazziari E et al (2019) Pelvic floor rehabilitation for defecation disorders. Tech Coloproctol 23:101–115. https://doi.org/10.1007/s10151-018-1921-z
Rao SS, Benninga MA, Bharucha AE, Chiarioni G, Di Lorenzo C, Whitehead WE (2015) ANMS-ESNM position paper and consensus guidelines on biofeedback therapy for anorectal disorders. Neurogastroenterol Motil 27:594–609. https://doi.org/10.1111/nmo.12520
Ascanelli S, Portinari M, Canella M et al (2021) Obstructed defecation syndrome associated with paradoxical puborectalis contraction: osteopathic treatment versus anal biofeedback. Results of a pilot study. Tech Coloproctol 25:589–595. https://doi.org/10.1007/s10151-020-02381-9
Wald A, Caruana BJ, Freimanis MG, Bauman DH, Hinds JP (1990) Contributions of evacuation proctography and anorectal manometry to evaluation of adults with constipation and defecatory difficulty. Dig Dis Sci 35:481–487. https://doi.org/10.1007/BF01536923
Rao SS, Patcharatrakul T (2016) Diagnosis and treatment of dyssynergic defecation. J Neurogastroenterol Motil 22:423–435. https://doi.org/10.5056/jnm16060
Rao SS, Valestin J, Brown CK, Zimmerman B, Schulze K (2010) Long-term efficacy of biofeedback therapy for dyssynergic defecation: randomized controlled trial. Am J Gastroenterol 105:890–896. https://doi.org/10.1038/ajg.2010.53
Rao SSC, Valestin JA, Xiang X, Hamdy S, Bradley CS, Zimmerman MB (2018) Home-based versus office-based biofeedback therapy for constipation with dyssynergic defecation: a randomised controlled trial. Lancet Gastroenterol Hepatol 3:768–777. https://doi.org/10.1016/S2468-1253(18)30266-8
Rao SSC, Go JT, Valestin J, Schneider J (2019) Home biofeedback for the treatment of dyssynergic defecation: does it improve quality of life and is it cost-effective? Am J Gastroenterol 114:938–944. https://doi.org/10.14309/ajg.0000000000000278
Frank L, Kleinman L, Farup C, Taylor L, Miner P Jr (1999) Psychometric validation of a constipation symptom assessment questionnaire. Scand J Gastroenterol 34:870–877. https://doi.org/10.1080/003655299750025327
Marquis P, De La Loge C, Dubois D, McDermott A, Chassany O (2005) Development and validation of the patient assessment of constipation quality of life questionnaire. Scand J Gastroenterol 40:540–551. https://doi.org/10.1080/00365520510012208
Chiarioni G, Kim SM, Vantini I, Whitehead WE (2014) Validation of the balloon evacuation test: reproducibility and agreement with findings from anorectal manometry and electromyography. Clin Gastroenterol Hepatol 12:2049–2054. https://doi.org/10.1016/j.cgh.2014.03.013
Funding
None.
Author information
Authors and Affiliations
Contributions
JC and LM developed the device hardware; HZ designed the device software; JC performed the biofeedback training; FX and LZ analyzed the data; JC, YX, and TC wrote the manuscript, JC revised the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
Jianfeng Chen and Liyi Ma are employees of Ningbo Medkinetic Medical Device Co, and Hongbing Zhu is an employee of Transtimulation Research Inc, the companies that developed the biofeedback training device for this study and intended to gain regulatory approval for marketing the device in future.
Ethical approval
The study was approved by the Ethics Committee of Yinzhou People's Hospital. All patients signed a written informed consent.
Human and animal rights
This study was performed following guidelines and regulations of the Declaration of Helsinki and approved by the Ethics Committee of Yinzhou People’s Hospital.
Informed consent
All participants signed the written informed consent.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Cheng, J., Xu, F., Ma, L. et al. A novel wireless, smartphone-based biofeedback training device for functional defecatory disorders: a pilot study. Tech Coloproctol 26, 61–65 (2022). https://doi.org/10.1007/s10151-021-02540-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10151-021-02540-6